Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Matsuda

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Neuropsychopharmacology Reports|October 22, 2021
Transcranial magnetic stimulation modalities for psychiatric disorders: Publication trends from 1985 to 2019Yuki Matsuda, Ryuichi Yamazaki, Masahiro Shigeta, et al.
Neuropsychopharmacology Reports|July 9, 2019
Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysisTaro Kishi, Toshikazu Ikuta, Yuki Matsuda, et al.
BMC Genomics|November 25, 2025
Genomic origin and consequence of captive red junglefowl in zoological parksYuki Matsuda, Masaki Eda, Shuichi Ito, et al.
The Journal of Clinical Psychiatry|January 18, 2014
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trialsTaro Kishi, Yuki Matsuda, Nakao Iwata, et al.
Journal of Psychiatric Research|May 26, 2019
Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Toshikazu Ikuta, Kenji Sakuma, et al.
Pharmacopsychiatry|January 31, 2020
Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in JapanTaro Kishi, Reiji Yoshimura, Yuki Matsuda, et al.
Bipolar Disorders|January 20, 2023
Repetitive transcranial magnetic stimulation for mania: A systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Yuki Matsuda, et al.
Psychiatry Research|September 1, 2023
Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Yuki Matsuda, et al.
Journal of Psychiatric Research|August 1, 2013
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trialsTaro Kishi, Tomohiko Mukai, Yuki Matsuda, et al.
Neuropsychopharmacology Reports|November 9, 2024
Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort studyAmi Nakazawa, Yuki Matsuda, Ryuichi Yamazaki, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Neuropsychopharmacology Reports|October 22, 2021
Transcranial magnetic stimulation modalities for psychiatric disorders: Publication trends from 1985 to 2019Yuki Matsuda, Ryuichi Yamazaki, Masahiro Shigeta, et al.
Neuropsychopharmacology Reports|July 9, 2019
Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysisTaro Kishi, Toshikazu Ikuta, Yuki Matsuda, et al.
BMC Genomics|November 25, 2025
Genomic origin and consequence of captive red junglefowl in zoological parksYuki Matsuda, Masaki Eda, Shuichi Ito, et al.
The Journal of Clinical Psychiatry|January 18, 2014
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trialsTaro Kishi, Yuki Matsuda, Nakao Iwata, et al.
Journal of Psychiatric Research|May 26, 2019
Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Toshikazu Ikuta, Kenji Sakuma, et al.
Pharmacopsychiatry|January 31, 2020
Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in JapanTaro Kishi, Reiji Yoshimura, Yuki Matsuda, et al.
Bipolar Disorders|January 20, 2023
Repetitive transcranial magnetic stimulation for mania: A systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Yuki Matsuda, et al.
Psychiatry Research|September 1, 2023
Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Yuki Matsuda, et al.
Journal of Psychiatric Research|August 1, 2013
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trialsTaro Kishi, Tomohiko Mukai, Yuki Matsuda, et al.
Neuropsychopharmacology Reports|November 9, 2024
Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort studyAmi Nakazawa, Yuki Matsuda, Ryuichi Yamazaki, et al.
Pageof 13